Metabolic Responses to Exercise and Recovery
Launched by UNIVERSITY COLLEGE, LONDON · Oct 11, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Metabolic Responses to Exercise and Recovery," is exploring how exercise affects our bodies and how we recover afterward. The researchers want to find out the best levels of exercise for improving health, especially since this might change depending on a person's age and sex. To do this, they will study 48 healthy and active participants from three different age groups: children aged 8-10, young adults aged 23-27, and older adults aged 53-57.
To participate, individuals need to be healthy, active, and fit within certain weight guidelines. Participants will first fill out a questionnaire to see if they qualify, and if selected, they will spend about 4-5 hours in an exercise lab. During their visit, they will complete a treadmill exercise, and researchers will collect some samples (blood from adults and saliva from everyone) before the exercise, right after, and one hour later. This study is currently recruiting participants, so if you or someone you know fits the age and health criteria, this could be a great opportunity to contribute to understanding how exercise benefits our health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 8-10, 23-27 or 53-57
- • 2. Considered healthy without a disease, disability or other condition that would impair participation in physical activity.
- • 3. Considered active.
- • 4. A body mass index within the ranges of 19 to 24.5 (adults) or the 2nd and 99th percentile (children)
- Exclusion Criteria:
- • 1. Outside required age brackets
- • 2. Having a disease, disability or other condition that would impair participation in physical activity.
- • 3. Having an implanted cardiac pacemaker, defibrillator, or other electronic medical devices.
- • 4. Receiving prescription medication one or more days every week over the past 3 months (some medications are permitted).
- • 5. Related by blood to another participant.
- • 6. Not willing at the time of recruitment to undergo blood sampling (adults only).
- • 7. Pregnancy/breastfeeding (adults only).
- • 8. Being a professional athlete.
- • 9. Not being physically active.
- • 10. Being a shift worker (night shift work for three or more days per week on more than two occasions in the six months before the visit day; adults only).
- • 11. Recent weight loss of more than 5% of weight in the last 6 months.
- • 12. Having a body mass index outside the range of 19 to 24.5 (adults) or outside the 2nd and 99th percentile (children)
- • 13. Smoking/vaping.
- • 14. Alcohol intake above a UK National Health Service (NHS) questionnaire cut-off.
- • 15. Regular use of recreational drugs.
- • 16. Not having reached menopause (for women aged 53-57 only).
About University College, London
University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Jonathan Wells, Professor
Principal Investigator
University College, London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported